Who
Claire Fraser
Director
Company insider
Files Form 4 as: Director, Seres Therapeutics; Director, Waters; Director, Becton, Dickinson and.
In numbers
- Trades disclosed
- 40
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $1.9M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 30 Jan 2007
- Last trade
- 8 Jul 2026
- Last filed
- 10 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jul 2026filed 10 Jul 2026 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,500 at $0.00 | filing |
| 8 Jul 2026filed 10 Jul 2026 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,500 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —358 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —877 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —877 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —358 at $0.00 | filing |
| 10 Sep 2025filed 11 Sep 2025 | BDX Becton, Dickinson andMedical Devices | SEC FORM 4 Sold | $172K917 at $187.50 | filing |
| 8 Aug 2025filed 8 Aug 2025 | BDX Becton, Dickinson andMedical Devices | SEC FORM 4 Sold | $166K863 at $192.30 | filing |
| 1 Jul 2025filed 2 Jul 2025 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,452 at $0.00 | filing |
| 10 Apr 2025filed 11 Apr 2025 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 28 Jan 2025filed 30 Jan 2025 | BDX Becton, Dickinson andMedical Devices | SEC FORM 4 Code A | —930 at $0.00 | filing |
| 4 Apr 2024filed 8 Apr 2024 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 23 Jan 2024filed 25 Jan 2024 | BDX Becton, Dickinson andMedical Devices | SEC FORM 4 Code A | —900 at $0.00 | filing |
| 28 Aug 2023filed 30 Aug 2023 | BDX Becton, Dickinson andMedical Devices | SEC FORM 4 Sold | $239K848 at $281.66 | filing |
| 22 Jun 2023filed 23 Jun 2023 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 26 Jan 2023filed 26 Jan 2023 | BDX Becton, Dickinson andMedical Devices | SEC FORM 4 Code A | —848 at $0.00 | filing |
| 4 Jan 2023filed 5 Jan 2023 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 8 Feb 2022filed 10 Feb 2022 | BDX Becton, Dickinson andMedical Devices | SEC FORM 4 Sold | $228K841 at $271.70 | filing |
| 25 Jan 2022filed 27 Jan 2022 | BDX Becton, Dickinson andMedical Devices | SEC FORM 4 Code A | —820 at $0.00 | filing |
| 18 Aug 2021filed 18 Aug 2021 | BDX Becton, Dickinson andMedical Devices | SEC FORM 4 Sold | $97K387 at $251.58 | filing |
News
Wagner Wealth Management Corp Acquires New Stake in Becton, Dickinson and Company $BDXBDX · dailypolitical.com · 21 Oct 2026Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focusBDX · seekingalpha.com · 11 Oct 2026
0 headlines in the last 90 days name Claire Fraser; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.